-
SPRO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Spero Therapeutics (SPRO)
Company Profile
Quarter (USD) | Sep 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 76.29 mm | 76.29 mm | 76.29 mm | 76.29 mm | 76.29 mm | |
Cash burn (monthly) | 14.33 k | 1.66 mm | 6.20 mm | (no burn) | 1.68 mm | |
Cash used (since last report) | 40.37 k | 4.69 mm | 17.45 mm | n/a | 4.73 mm | |
Cash remaining | 76.25 mm | 71.60 mm | 58.84 mm | n/a | 71.56 mm | |
Runway (months of cash) | 5319.7 | 43.0 | 9.5 | n/a | 42.6 |
13F holders | Current |
---|---|
Total holders | 28 |
Opened positions | 8 |
Closed positions | 31 |
Increased positions | 1 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 3.72 bn |
Total shares | 18.50 mm |
Total puts | 1.00 k |
Total calls | 500.00 |
Total put/call ratio | 2.0 |
Largest owners | Shares | Value |
---|---|---|
GSK GSK | 9.19 mm | $18.66 mm |
PFE Pfizer | 2.36 mm | $32.98 mm |
Atlas Venture Fund IX | 1.38 mm | $22.05 mm |
Atlas Venture Fund X | 1.03 mm | $20.98 mm |
GV 2015 | 889.98 k | $17.26 mm |
Lundbeckfond Invest A/S | 877.49 k | $8.44 mm |
Murchinson | 873.91 k | $1.14 bn |
Novo Holdings A/S | 468.90 k | $609.57 mm |
AWM Investment | 333.40 k | $433.42 mm |
Citadel Advisors | 312.03 k | $405.64 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Nov 24 | Esther Rajavelu | Common Stock | Sell | Dispose S | No | No | 1.3 | 17,245 | 22.42 k | 379,270 |
7 Nov 24 | Esther Rajavelu | Common Stock | Sell | Dispose S | No | No | 1.31 | 23,351 | 30.59 k | 396,515 |
27 Aug 24 | Mahadevia Ankit | Common Stock | Sell | Dispose S | No | No | 1.35 | 5,912 | 7.98 k | 759,085 |
27 Aug 24 | Timothy Keutzer | Common Stock | Sell | Dispose S | No | No | 1.35 | 2,213 | 2.99 k | 531,837 |
27 Aug 24 | Sath Shukla | Common Stock | Sell | Dispose S | No | No | 1.35 | 2,757 | 3.72 k | 1,140,809 |
29 May 24 | John C Pottage Jr | Common Stock | Grant | Acquire A | No | No | 0 | 20,000 | 0.00 | 55,000 |